,7,8 As a result, reversing the underlying immunosuppression present in most IFS cases with leukocyte infusions, granulocyte-macrophage colony-stimulating factor, and other immunomodulating agents have been explored with mixed results.16 This evidence concerns the gene CSF2 and congenital fibrosarcoma.